Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy.

Radovan VojtíšekJan BaxaPetra KovářováAmira AlmortazaPetr HošekEmília SukovskáRadek TupýJiří FerdaJindřich Fínek

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2021)

Our study confirmed that when using the midtreatment PET/MRI we are able to identify metabolic parameters having the discrimination ability for the prediction of non-CMR. In particular mid-MTV‑S, mid-MTV, mid-tumor size, mid-TLG‑S, mid-TLG and ∆%SUVmax.

Keyphrases

locally advanced
rectal cancer
magnetic resonance imaging
computed tomography
squamous cell carcinoma
contrast enhanced
neoadjuvant chemotherapy
pet ct
diffusion weighted imaging
magnetic resonance